ScholarIQanswers from OpenAlex
Uterine Myomas and Treatments
TopicLeading institutions, researchers & key papers
Uterine Myomas and Treatments is a topic indexed in ScholarIQ from OpenAlex.
What is known about Uterine Myomas and Treatments?
ScholarIQrecord summary
This cluster of papers focuses on various aspects of uterine conditions and their treatments, including uterine leiomyoma (fibroids), hysterectomy, uterine sarcomas, uterine artery embolization, reproductive outcomes after different treatments, MRI guidance for treatment, the role of progesterone, and the impact on health-related quality of life. The cluster also covers epidemiological studies related to uterine conditions.
How many works does Uterine Myomas and Treatments have?
ScholarIQindexed works
Uterine Myomas and Treatments has 293 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Uterine Myomas and Treatments?
ScholarIQopenalex
The OpenAlex for Uterine Myomas and Treatments is on the source record.
What are the most-cited papers on Uterine Myomas and Treatments?
ScholarIQmost cited works
Assessment of menstrual blood loss using a pictorial chart
Jenny Higham, P.M.S. O’Brien, Robert W. Shaw
Nationwide Trends in the Performance of Inpatient Hysterectomy in the United States
Jason D. Wright, Thomas J. Herzog, Jennifer Tsui, Cande V. Ananth, Sharyn N. Lewin, Yu‐Shiang Lu, Alfred I. Neugut, Dawn L. Hershman
Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group
T. Van den Bosch, Margit Dueholm, F. Leone, L. Valentin, C Rasmussen, A. Votino, Dominique Van Schoubroeck, C. Landolfo, Arnaud Installé, S. Guerriero, C. Exacoustós, Stephan Gordts, Beryl R. Benacerraf, Thomas D’Hooghe, Bart De Moor, Hans A.M. Brölmann, Steven R. Goldstein, E. Epstein, T. Bourne, D. Timmerman
Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma: Results of a Phase II Trial
Martee L. Hensley, Robert G. Maki, Ennapadam Venkatraman, Gennifer Geller, Meghan Lovegren, Carol Aghajanian, Paul Sabbatini, William P. Tong, Richard R. Barakat, David R. Spriggs
Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy☆
Robert Giuntoli, Daniel S. Metzinger, Connie S. DiMarco, Stephen S Cha, Jeff A. Sloan, Gary L. Keeney, Bobbie S. Gostout
Where is Uterine Myomas and Treatments research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Uterine Myomas and Treatments is open access?
ScholarIQopen access share
53%OPEN ACCESS